Resources|Articles|November 8, 2024
mAbs Scale-up video
Author(s)Avantor
Scaling up monoclonal antibody (mAb) production can be challenging, but it doesn't have to slow you down. Explore how our large-volume handling solutions, GMP-grade chemicals and customized solutions for process development, optimization, and validation help you scale up quickly and meet regulatory standards with confidence.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
Trending on Pharmaceutical Technology
1
FAQ: Pharmaceutical Outsourcing Trends and Innovations
2
FAQ: Everything to Know about 3D Printing in Pharma Manufacturing and Packaging
3
Lilly Launches UK Trial of Weight-Loss Drug as US Price Drops
4
Drug Solutions Podcast: Innovations in Orphan Drugs for Rare Diseases
5
